Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies
Biomolecules · 22.11.2024 · 14 (12) · 1485
DOI: 10.3390/biom14121485 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.11.2024. Verfasst von Yuchen Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Hedgehog Proteins, Signal Transduction, Fibrosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Regional Innovation Cooperation Project of Science and Technology Department of Sichuan Province, Sichuan Provincial Cadre Healthcare Research Program.
Abstract (Originalsprache)
Hedgehog (Hh) signaling is a well-established developmental pathway; it is crucial for early embryogenesis, cell differentiation, and damage-driven regeneration. It is being increasingly recognized that dysregulated Hh signaling is also involved in fibrotic diseases, which are characterized by excessive extracellular matrix deposition that compromises tissue architecture and function. As in-depth insights into the mechanisms of Hh signaling are obtained, its complex involvement in fibrosis is gradually being illuminated. Notably, some Hh-targeted inhibitors are currently under exploration in preclinical and clinical trials as a means to prevent fibrosis progression. In this review, we provide a concise overview of the biological mechanisms involved in Hh signaling. We summarize the latest advances in our understanding of the roles of Hh signaling in fibrogenesis across the liver, kidneys, airways, and lungs, as well as other tissues and organs, with an emphasis on both the shared features and, more critically, the distinct functional variations observed across these tissues and organs. We thus highlight the context dependence of Hh signaling, as well as discuss the current status and the challenges of Hh-targeted therapies for fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
- Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China.
- Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.
ORCID-Profile: Yuwei Zhang
Förderung
- National Natural Science Foundation of China
- Regional Innovation Cooperation Project of Science and Technology Department of Sichuan Province
- Sichuan Provincial Cadre Healthcare Research Program
Zitieren
APA
Hu, Y., Peng, L., Zhuo, X., Yang, C., & Zhang, Y. (2024). Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies. Biomolecules, 14(12), 1485. https://doi.org/10.3390/biom14121485
Vancouver
Hu Y, Peng L, Zhuo X, Yang C, Zhang Y. Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies. Biomolecules. 2024;14(12):1485. doi:10.3390/biom14121485
BibTeX
@article{Hu2024,
author = {Hu, Yuchen and Peng, Linrui and Zhuo, Xinyu and Yang, Chan and Zhang, Yuwei},
title = {Hedgehog Signaling Pathway in Fibrosis and Targeted Therapies},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {12},
pages = {1485},
doi = {10.3390/biom14121485}
}
EUVIMED